HEALTH TECHNOLOGY, MEDICAL DEVICES
Koelsch Communities | February 06, 2023
Koelsch Communities made a significant announcement recently regarding an investment in its tech-forward future. The company has decided to develop a partnership with August Health to integrate the latter's innovative resident care platform across its portfolio of over 40 communities in eight states.
Aaron Koelsch, President and CEO of Koelsch Communities, remarked, "Investing in technology that improves how we serve residents, their families and our dedicated team members is the way forward, and we are proud to be at the forefront of this movement in senior living."
He added, "Koelsch is a unique company in that we honor tradition and respect deeply the dignity of each resident, which is why we harness some of today's most advanced senior care technologies as a way to improve, adapt and innovate to fulfill that mission."
(Source – Business Wire)
August Health will help Koelsch digitally change with an easy-to-use platform that improves care workflows and gives caregivers and families essential insights. It offers a paperless move-in experience in an industry known for its paperwork. The platform guides users through best practices in clinical assessments, resident care, compliance, and analytics.
August Health Co-Founder and Co-CEO Dr. Justin Schram expressed, "We are thrilled to partner with Koelsch, a recognized national senior living leader, to further modernize their operations and support their exceptionally high standard of resident care."
He continued, "Operators like Koelsch face new challenges related to increased resident acuity, a tightening regulatory environment, and competitive labor markets. Our modern resident care platform enables them to excel in today's environment while positioning them for growth in the years ahead."
(Source – Business Wire)
About Koelsch Communities
Koelsch Communities is a third-generation, family-owned senior living company. For over 60 years, the company has specialized in independent living, assisted living, and memory care. It offers first-class service, a holistic care model, and an employee-centric company culture. The company also helps to fund new programs that make healthy aging possible and builds a safe base with the latest security and technology.
Read More
HEALTHTECH SECURITY
KORU Medical | October 13, 2022
KORU Medical Systems, Inc. a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions announced the appointment of Brent Rutland as the Company’s new Vice President of Medical Affairs. Mr. Rutland will provide leadership in the Company’s clinical and data generation strategies, key opinion leader engagement, assessing new subcutaneous drug candidates for use with the Company’s products and overseeing the medical affairs team. Additionally, Mr. Rutland will be the clinical resource for the Company’s efforts in regulatory submissions, failure modes and effects analysis, health hazard evaluations, human factors design, new product development and clinical evaluation updates.
“We are excited to bring Brent’s competence to the organization – his background was a perfect fit. His expertise will advance clinical evidence generation in support of our product pipeline, provide valuable insight to our drug therapy candidates and help develop important key opinion leader relationships. Brent has helped build multiple data and clinical strategies, internal teams, and external networks in his past. His deep industry experience and passion for the patient, will make him an impactful contributor to the Company’s strategy.”
Linda Tharby, President and CEO
Mr. Rutland’s career history spans an impressive 27 years and includes working with Baxter Healthcare as a Senior Medical Science Liaison and most recently with La Jolla Pharmaceutical Company as a Senior Director, Health Outcomes. During his career he helped launch 7 vaccines, 4 drugs and 1 device. Most notably, Brent aided Baxter in the launch of Hylenex for SQ rehydration where he also helped build the Medical Affairs department. He has received several awards throughout his career, with the most recent being the President’s Circle Award for Medical Affairs at La Jolla. Brent holds a Bachelor of Science degree from Texas A&M University, an MBA in Global Management from the University of Houston, and his Master of Public Health from the University of North Carolina in Epidemiology.
“I was immediately drawn to the opportunity to work at KORU Medical as I saw the potential for future growth supported by building out the medical science and the team,” said Brent Rutland, Vice President of Medical Affairs. “Medical affairs helps fulfill the unmet needs of the patient through the generation and delivery of scientific evidence to various key outside stakeholders. I look forward to developing a collaborative strategy to support the Company’s overall goals.”
About KORU Medical
KORU Medical develops, manufactures, and commercializes innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System. currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.
Read More
July 20, 2016
GlaxoSmithKline Consumer Healthcare has consolidated its global agency roster to nine shops across advertising, digital, content, PR, expert marketing and shopper marketing to support its leading brands, such as Sensodyne and Theraflu.
Read More